Cited by 407Sexual function and dysfunction studiesTreatment of Major DepressionSchizophrenia research and treatment

The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.

Antidepressant-Induced Sexual Dysfunction

Gregorian, Razmic S, Golden, Katharine A, Bahce, Asena, Goodman, Clifford, Kwong, W Jacqueline, Khan, Zeba M·2002·Annals of Pharmacotherapy

DOI 10.1345/aph.1a195

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To review the evidence regarding antidepressant-induced sexual dysfunction and address implications for treatment strategy and health plan coverage policies for antidepressant medications. DATA SOURCES: Primary articles were identified by a MEDLINE and HealthSTAR search to identify English-language studies published between January 1986 and July 2000. Search terms included sexual dysfunction or sexual function and antidepressants, fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, venlafaxine, nefazodone, bupropion, and mirtazapine. A cross-check of references cited in 10 published reviews yielded additional in-scope articles. STUDY SELECTION AND DATA EXTRACTION: Approximately 200 articles were identified, including 8 randomized controlled trials and numerous open-label studies, case series, and case reports. Of the randomized controlled trials, only 5 were designed to evaluate the incidence of sexual dysfunction associated with antidepressant treatment. Three additional randomized controlled trials included a structured assessment of sexual dysfunction within an efficacy trial. Data extraction excluded case reports, letters, and other limited study designs. A panel survey augmented published reports. DATA SYNTHESIS: Sexual dysfunction is a relatively common adverse effect of many of the antidepressants in common use today. Rates of sexual dysfunction observed in clinical practice may be higher than those reported in the product information for several agents. Selective serotonin-reuptake inhibitors (SSRIs) appear to be the class of antidepressants most likely to cause sexual dysfunction. Published studies suggest that between 30% and 60% of SSRI-treated patients may experience some form of treatment-induced sexual dysfunction. Bupropion and nefazodone appear to be much less likely to cause sexual dysfunction (≤10% of patients). Mirtazapine also appears to be associated with a low rate of sexual adverse effects. Panel results largely reflect the consensus of the literature. CONCLUSIONS: Sexual dysfunction is a common adverse effect of antidepressant treatment. Physicians should monitor their patients for antidepressant-induced sexual adverse effects, as these may affect compliance with therapy and ultimate treatment success. In addition to the consequences for patient health and well-being, managed-care organizations should be concerned with sexually related adverse effects of antidepressants, insofar as additional healthcare resources may be required to treat depressed patients in whom these adverse effects arise.

Integrity signals

Registry

Crossref · 10.1345/aph.1a195

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236

Show all 71 references

Research works printed but not linked: 21

Preskorn SH, 1995, J Clin Psychiatry, 56, 12
Patterson WM, 1993, J Clin Psychiatry, 54, 71
Feiger A, 1996, J Clin Psychiatry, 57, 53
Zajecka J, 1991, J Clin Psychiatry, 52, 66
Herman JB, 1990, J Clin Psychiatry, 51, 25
Segraves RT, 1998, J Clin Psychiatry, 59, 48
Segraves RT, 1993, J Clin Psychiatry Monogr, 11, 57
Rothschild AJ, 2000, J Clin Psychiatry, 61, 28
Hirschfeld RM, 1999, J Clin Psychiatry, 60, 32
Reimherr FW, 1990, J Clin Psychiatry, 51, 18
1994, Diagnostic and statistical manual for psychiatric disorders
Harrison WM, 1985, Psychopharmacol Bull, 21, 85
Balon R, 1993, J Clin Psychiatry, 54, 209
Zajecka J, 1997, Psychopharmacol Bull, 33, 755
Jacobsen FM, 1992, J Clin Psychiatry, 53, 119
Walker PW, 1993, J Clin Psychiatry, 54, 459
1999, Delphi Panel investigation of antidepressant related sexual dysfunction and breakthrough symptoms
Balon R, 1993, J Clin Psychiatry, 54, 161
Hollander E, 1992, J Clin Psychiatry, 53, 207
Balogh S, 1992, J Clin Psychiatry, 53, 212
Sussman N, 1994, J Clin Psychiatry, 55, 45

Sorted by citations

Items 101–200 of 407

Sex-Specific Differences in Side Effects of Psychotropic Drugs: Genes or Gender?
Haack, S., Seeringer, A., Thürmann, P., Becker, T. M., & Kirchheiner, J. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.102 · Cited by 103
Modifying Risk Factors to Prevent and Treat Erectile Dysfunction
Glina, S., Sharlip, I. D., & Hellstrom, W. J. G. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02816.x · Cited by 101
Levetiracetam and brivaracetam: A review of evidence from clinical trials and clinical experience
Steinhoff, B. J., & Staack, A. M. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419873518 · Cited by 99
Sexual dysfunction and chronic pain: the role of psychological variables and impact on quality of life
Kwan, K. S. H., Roberts, L. J., & Swalm, D. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2004.12.008 · Cited by 99
Sexual Desire and Hypoactive Sexual Desire Disorder in Women. Introduction and Overview. Standard Operating Procedure (SOP Part 1)
Bitzer, J., Giraldi, A. G. E., & Pfaus, J. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02818.x · Cited by 101
Multiple sclerosis and sexual dysfunction
Guo, Z., He, S., Zhang, H., Wu, J., & Yang, Y. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.110 · Cited by 100
Serotonin and the neurobiology of the ejaculatory threshold.
de Jong, T. D., Veening, J., Waldinger, M., Cools, A., & Olivier, B. (2006) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.01.001 · Cited by 99
Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression
Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2009) · CNS Drugs · doi:10.2165/11319480-000000000-00000 · Cited by 95
A strategy to advance the evidence base in palliative medicine: Formation of a palliative care research cooperative group
Abernethy, A. P., Aziz, N. M., Basch, E., Bull, J., Cleeland, C. S., Currow, D. C., Fairclough, D., Hanson, L., Hauser, J., Ko, D., et al. (2010) · Journal of Palliative Medicine · doi:10.1089/jpm.2010.0261 · Cited by 94
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause
Archer, D. F., Seidman, L. S., Constantine, G. D., Pickar, J. H., & Olivier, S. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.09.877 · Cited by 96
Sexual Function during Bupropion or Paroxetine Treatment of Major Depressive Disorder
Kennedy, S. H., Fulton, K., Bagby, R. M., Greene, A. L., Cohen, N. L., & Rafi‐Tari, S. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100405 · Cited by 94
“Antidepressant medications may also interfere with SF, often resulting in orgasmic or ejaculatory difficulties (4,5,6).”
Background
Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy
Dell’Osso, B. M., Buoli, M., Baldwin, D. S., & Altamura, A. C. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1074 · Cited by 94
Modifying Risk Factors in the Management of Erectile Dysfunction: A Review
DeLay, K. J., Haney, N. M., & Hellstrom, W. J. G. (2016) · The World Journal of Men s Health · doi:10.5534/wjmh.2016.34.2.89 · Cited by 97
The Association of Physical and Mental Health with Sexual Activity in Older Adults in a Retirement Community
Bach, L. E., Mortimer, J. A., VandeWeerd, C. L., & Corvin, J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12308 · Cited by 89
Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?
Bijlsma, E. Y., Chan, J. S. W., Olivier, B., Veening, J. G., Millan, M. J., Waldinger, M. D., & Oosting, R. S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.004 · Cited by 89
“Dose-dependent inhibiting effects of the SSRI paroxetine Paroxetine (and most other SSRIs (Gregorian et al. , 2002, Montejo-Gonzalez et al., 1997, Waldinger et al., 1998b)) have strong inhibitory effects on sexual behavior of humans, both in healthy individuals (Waldinger et al. , 2007) and in…”
Intranasal delivery of icariin via a nanogel-thermoresponsive hydrogel compound system to improve its antidepressant-like activity
Xu, D. W., Lu, Y., Kou, N., Hu, M.-J., Wang, Q., & Cui, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119550 · Cited by 88
Strategies for the treatment of antidepressant-related sexual dysfunction.
Zajecka, J. (2001) · PubMed · Cited by 86
Prevalence and risk factors of muscle complications secondary to statins
El‐Salem, K., Ababneh, B., Rudnicki, S., Malkawi, A., Alrefai, A., Khader, Y., Saadeh, R., & Saydam, M. (2011) · Muscle & Nerve · doi:10.1002/mus.22205 · Cited by 83
Myopathy with statin–fibrate combination therapy: clinical considerations
Jacobson, T. A. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.151 · Cited by 82
The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk
Corsini, A. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026132412074 · Cited by 82
Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion
Abler, B., Seeringer, A., Hartmann, A., Grön, G., Metzger, C. D., Walter, M., & Stingl, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.66 · Cited by 84
Older adults' satisfaction with a medication dispensing device in home care
Reeder, B., Demiris, G., & Marek, K. D. (2013) · Informatics for Health and Social Care · doi:10.3109/17538157.2012.741084 · Cited by 75
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review - Part I: Antidepressants
Torre, A. L., Giupponi, G., Duffy, D. M., & Conca, A. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1345205 · Cited by 85
The antidepressant fluoxetine alters mechanisms of pre- and post-copulatory sexual selection in the eastern mosquitofish (Gambusia holbrooki)
Bertram, M. G., Ecker, T. E., Wong, B. B. M., O’Bryan, M. K., Baumgartner, J. B., Martin, J. M., & Saaristo, M. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.03.006 · Cited by 83
Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine
Landén, M., Högberg, P., & Thase, M. E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0114 · Cited by 82
Determinants of sexual dysfunction in women with multiple sclerosis
Mohammadi, K., Rahnama, P., Mohseni, S. M., Sahraian, M. A., & Montazeri, A. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-83 · Cited by 84
Persistent Genital Arousal Disorder in Women: Case Reports of Association with Anti-Depressant Usage and Withdrawal
Leiblum, S. R., & Goldmeier, D. (2008) · Journal of Sex & Marital Therapy · doi:10.1080/00926230701636205 · Cited by 82
“In fact, lower rates of medication adherence may occur as a result of unwanted sexual side effects (Gregorian et al., 2002; Nurnberg & Hensley, 2003; Roose, 1999; Rosenberg, Bleiberg, Koscis, & Gross, 2003; Zajecka, 2000; Dobkin et al., 2006).”
Background
The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study
Djuv, A., Nilsen, O. G., & Steinsbekk, A. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-295 · Cited by 80
Antipsychotic maintenance treatment: time to rethink
Moncrieff, J. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001861 · Cited by 80
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆
Bortnick, B., El-Khalili, N., Banov, M. D., Adson, D. E., Datto, C. J., Raines, S. R., Earley, W. R., & Eriksson, H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.031 · Cited by 80
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders
Grigoriadis, D. E. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.651 · Cited by 75
Sexual difficulties and help-seeking among mature adults in Australia: results from the Global Study of Sexual Attitudes and Behaviours
Moreira, E. D., Glasser, D. B., King, R., Duarte, F. G., Gingell, C., & for the GSSAB Investigators' Group (2008) · Sexual Health · doi:10.1071/sh07055 · Cited by 76
Sexual Dysfunction Due to Psychotropic Medications
Clayton, A. H., Alkis, A. R., Parikh, N., & Votta, J. G. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.04.006 · Cited by 76
The safety and efficacy of Avanafil, a new 2 nd generation PDE5i: comprehensive review and meta-analysis
Corona, G., Rastrelli, G., Burri, A., Jannini, E. A., & Maggi, M. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1130126 · Cited by 71
Sexual disorders in women with MS: Assessment and management
Cordeau, D., & Courtois, F. (2014) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2014.05.008 · Cited by 76
“[54] report a significant contribution of antidepressant side effects on female sexual function.”
Background
The Serotonin Transporter Plays an Important Role in Male Sexual Behavior: A Study in Serotonin Transporter Knockout Rats
Chan, J. S. W., Snoeren, E. M. S., Cuppen, E. P. J. G., Waldinger, M. D., Olivier, B., & Oosting, R. S. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01961.x · Cited by 70
Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status
Çakar, E., Dinçer, Ü., Kıralp, M. Z., Taşkaynatan, M. A., Yaşar, E., Bayman, E. O., Özgül, A., & Dursun, H. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0545-x · Cited by 68
Sexual Dysfunction in the Older Woman
Walsh, K. E., & Berman, J. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421100-00004 · Cited by 71
A literature review to investigate the link between psychosocial characteristics and treatment adherence in cancer patients
Theofilou, P., & Panagiotaki, H. (2012) · Oncology Reviews · doi:10.4081/oncol.2012.e5 · Cited by 67
Sexual Activity and Function in Postmenopausal Women With Heart Disease
Addis, I. B., Ireland, C. C., Vittinghoff, E., Lin, F., Stuenkel, C. A., & Hulley, S. B. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000165276.85777.fb · Cited by 67
Exercise improves depression through positive modulation of brain-derived neurotrophic factor (BDNF). A review based on 100 manuscripts over 20 years
Jemni, M., Zaman, R., Carrick, F. R., Clarke, N. D., Marina, M., Bottoms, L. M., Matharoo, J. S., Ramsbottom, R., Hoffman, N., Groves, S. J., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1102526 · Cited by 83
“Earlier studies confirmed sexual dysfunction is a common side effect of antidepressant treatment (Gregorian et al., 2002).”
Background
A Systematic Review of the Utility of Anticonvulsant Pharmacotherapy in the Treatment of Vulvodynia Pain
Leo, R. J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12200 · Cited by 67
Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting
Lee, K.-U., Lee, Y. M., Nam, J.-M., Lee, H.-K., Kweon, Y.-S., Lee, C. T., & Jun, T.-Y. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.1.55 · Cited by 63
Long-term side effects of SSRIs: sexual dysfunction and weight gain.
Hirschfeld, R. M. A. (2003) · PubMed · Cited by 60
Sexual Dysfunction and Psychotropic Medications
Stimmel, G. L., & Gutierrez, M. A. (2006) · CNS Spectrums · doi:10.1017/s1092852900026730 · Cited by 60
Care management for depression in primary care practice: findings from the RESPECT-depression trial
Nutting, P. A., Gallagher, K., Riley, K., White, S., Dickinson, W. P., Korsen, N., & Dietrich, A. (2008) · The Annals of Family Medicine · doi:10.1370/afm.742 · Cited by 58
An Integrated Analysis of the Safety and Tolerability of Desvenlafaxine Compared with Placebo in the Treatment of Major Depressive Disorder
Clayton, A. H., Kornstein, S. G., Rosas, G. R., Guico‐Pabia, C. J., & Tourian, K. A. (2009) · CNS Spectrums · doi:10.1017/s1092852900020204 · Cited by 59
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder
Pigott, T. A., Prakash, A., Arnold, L. M., Aaronson, S. T., Mallinckrodt, C. H., & Wohlreich, M. M. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188107 · Cited by 59
A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis
Fallon, P., & Dursun, S. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109359097 · Cited by 56
The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line
Hansen, C. H., Larsen, L. W., Sørensen, A. M., Halling‐Sørensen, B., & Styrishave, B. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.02.001 · Cited by 56
“Between 30 and 60% of all SSRI users have been reported to suffer from sexual dysfunction (Gregorian et al., 2002).”
Background
Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors
Stryjer, R., Spivak, B., Strous, R. D., Shiloh, R., Harary, E., Polak, L., Birgen, M., Kotler, M., & Weizman, A. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31816d1cdc · Cited by 55
A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.
Bostwick, J. M. (2010) · Mayo Clinic proceedings · doi:10.4065/mcp.2009.0565 · Cited by 62
Symptoms and Treatment in Cancer Therapy-Induced Early Menopause
Boekhout, A. H., Beijnen, J. H., & Schellens, J. H. M. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-641 · Cited by 55
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
Janik, A., Qiu, X., Lane, R., Popova, V., Drevets, W. C., Canuso, C. M., Macaluso, M., Mattingly, G. W., Shelton, R. C., Zajecka, J. M., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1317 · Cited by 54
TIDAL WAVES: Network mechanisms in the neuroendocrine control of prolactin release
Lyons, D. J., & Broberger, C. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.001 · Cited by 65
Sexual Dysfunction in Clinically Stable Patients With Bipolar Disorder Receiving Lithium
Grover, S., Ghosh, A., Sarkar, S., Chakrabarti, S., & Avasthi, A. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000131 · Cited by 54
Serotonin-estrogen interactions: What can we learn from pregnancy?
Thibeault, A.-A. H., Sanderson, J. T., & Vaillancourt, C. (2019) · Biochimie · doi:10.1016/j.biochi.2019.03.023 · Cited by 56
Prevalence of sexual problems and related help-seeking behaviors among mature adults in Brazil: data from the global study of sexual attitudes and behaviors
Moreira, E. D., Glasser, D. B., dos Santos, D. B., & Gingell, C. (2005) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802005000500007 · Cited by 53
Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models
Dwyer, J. M., Rizzo, S. J. S., Webb, S. J. N., Lin, Q., Jow, F., Arias, R. L., Rosenzweig-Lipson, S. J., Dunlop, J., & Beyer, C. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1373-7 · Cited by 53
“Additionally, SSRIs such as Paxil® (paroxetine), while sometimes effective in treating anxiety, require chronic administration and produce side effects, such as sexual dysfunction ( Gregorian et al. 2002; Rothschild 2000) and nausea or vomiting (Greist et al. 2004).”
Background
Pharmacology of serotonin and female sexual behavior
Uphouse, L. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.008 · Cited by 52
“…in 5-HT functioning are thought to contribute to the sexual dysfunction that occurs following treatment with antidepressants such as selective serotonin reuptake inhibitors (SSRIs) (Clayton et al., 2006; Clayton, 2002; Gelenberg et al., 2000; Gregorian et al., 2002; Montgomery et al., 2002).”
BackgroundInfluential
Antidepressant-related sexual dysfunction — Perspectives from neuroimaging
Graf, H., Walter, M., Metzger, C. D., & Abler, B. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.003 · Cited by 53
Depression and sexual dysfunction
Hartmann, U. H. (2007) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2006.12.003 · Cited by 53
Maternal exposure to the antidepressant fluoxetine impairs sexual motivation in adult male mice
Gouvêa, T. S., Morimoto, H. K., de Faria, M. J. S. S., Moreira, E. G., & Gerardin, D. C. C. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.025 · Cited by 51
“Reduced libido is a classic adverse effect of chronic FLX treatment in humans (Gregorian et al., 2002; Clayton et al., 2006), and was already observed in adult rats chronically exposed to FLX (Matuszcyk et al., 1998).”
Background
Premature Ejaculation Associated with Citalopram Withdrawal
Adson, D. E., & Kotlyar, M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d214 · Cited by 50
Influences of dopamine and glutamate in the medial preoptic area on male sexual behavior
Will, R. G., Hull, E. M., & Dominguez, J. M. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.005 · Cited by 50
“Patients prescribed selective serotonin reuptake inhibitors (SSRIs) who reported impaired erectile function as well as decreased sexual interest (Gregorian et al., 2002).”
Background
A Systematic Review of the Utility of Antidepressant Pharmacotherapy in the Treatment of Vulvodynia Pain
Leo, R. J., & Dewani, S. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02915.x · Cited by 51
The Marketization of Depression: The Prescribing of SSRI Antidepressants to Women *
Currie, J. (2005) · Cited by 49
Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats
Uphouse, L. L., Hensler, J. G., Sarkar, J., & Grossie, B. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.033 · Cited by 49
Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study)
Parati, G., Omboni, S., Compare, A., Grossi, E., Callus, E., Venco, A., Destro, M., Villa, G., Palatini, P., Rosei, E. A., et al. (2013) · Trials · doi:10.1186/1745-6215-14-22 · Cited by 49
Treatment of pain in fibromyalgia patients with testosterone gel: Pharmacokinetics and clinical response
White, H. D., Brown, L., Gyurik, R. J., Manganiello, P. D., Robinson, T. D., Hallock, L. S., Lewis, L. D., & Yeo, K.-T. J. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.016 · Cited by 48
Persistent Sexual Arousal Syndrome: A Case Report and Review of the Literature
Mahoney, S. F., & Zarate, C. A. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600998532 · Cited by 48
Drugs that cause sexual dysfunction.
Smith, S. M. (1983) · PubMed · Cited by 48
Strategies for managing sexual dysfunction induced by antidepressant medication
Rudkin, L., Taylor, M. J., & Hawton, K. K. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003382.pub2 · Cited by 48
Interventions for psychosexual dysfunction in women treated for gynaecological malignancy
Flynn, P., Kew, F., & Kisely, S. R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004708.pub2 · Cited by 47
Religiousness/spirituality, cardiovascular disease, and cancer: Cultural integration for health research and intervention.
Masters, K. S., & Hooker, S. A. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0030813 · Cited by 45
Screening for depressive symptoms in an online sample of men who have sex with men
Hirshfield, S., Wolitski, R. J., Chiasson, M. A., Remien, R. H., Humberstone, M., & Wong, T. (2008) · AIDS Care · doi:10.1080/09540120701796892 · Cited by 45
“We also do not know whether depression itself or antidepressant medication may have affected respondents’ libido (Gregorian et al., 2002; Kennedy, Dickens, Eisfeld, & Bagby, 1999), partially explaining why a proportion did not report sex in the past three months.”
The sexual functioning of women with fibromyalgia
Kool, M. B., Prins, M., van Middendorp, H., Woertman, L., & Geenen, R. (2006) · PsycEXTRA Dataset · doi:10.1037/e524352011-004 · Cited by 45
The ‘real’ woman with heart failure: impact of sex on current in-hospital management of heart failure by cardiologists and internists.
Opasich, C., De Feo, S., Ambrosio, G. A., Bellis, P., Di Lenarda, A., Di Tano, G., Fico, D., Gonzini, L., Lavecchia, R., Tomasi, C., et al. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.11.021 · Cited by 44
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
Moncrieff, J., Gupta, S., & Horowitz, M. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320937910 · Cited by 43
Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials
Avigan, M., Bjornsson, E. S., Pasanen, M., Cooper, C. K., Andrade, R. J., Watkins, P. B., Lewis, J. H., & Merz, M. (2014) · Drug Safety · doi:10.1007/s40264-014-0183-6 · Cited by 43
Clonazepam for the Treatment of Panic Disorder
Nardi, A. E., Machado, S. E. D. C., Almada, L. F., Paes, F., Silva, A. C., Marques, R. J., Amrein, R., Freire, R. C. R., Martín‐Santos, R., Cosci, F., et al. (2013) · Current Drug Targets · doi:10.2174/1389450111314030007 · Cited by 41
“While no paper reported any serious AEs associated with clonazepam, there were a few reports of patients discontinuing clonazepam therapy due to tolerability problems, such as sedation, sleep disturbances, and/or nausea [62, 64, 71].”
Background
Sexual function in male long‐term survivors of childhood acute lymphoblastic leukemia
Haavisto, A., HENRIKSSON, M. M., Heikkinen, R., Puukko‐Viertomies, L., & Jahnukainen, K. (2016) · Cancer · doi:10.1002/cncr.29989 · Cited by 41
The Madness of Women: Myth and Experience
Ussher, J. M. (2021) · Springer eBooks · doi:10.1007/978-981-15-4106-3_34-1 · Cited by 40
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period
Dueñas, H., Brnabic, A. J. M., Lee, A. C.-L., Montejo, A. L., Prakash, S., Casimiro-Querubin, M. L. S., Khaled, M., Dossenbach, M. R. K., & Raskin, J. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.590209 · Cited by 40
Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management
Winter, J. R., Curtis, K. J., Hu, B., & Clayton, A. H. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2049753 · Cited by 42
The Effects of Citalopram and Fluoxetine on Sexual Behavior in Healthy Men: Evidence of Delayed Ejaculation and Unaffected Sexual Desire. A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy, Parallel Group Study
Madeo, B., Bettica, P. U., Milleri, S., Antonio, B., Granata, A. R. M., Carani, C., & Rochira, V. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00843.x · Cited by 40
Sexual Arousal and Lubrication Problems in Women With Clinically Diagnosed Hypoactive Sexual Desire Disorder: Preliminary Findings from the Hypoactive Sexual Desire Disorder Registry for Women
Maserejian, N. N., Shifren, J. L., Parish, S. J., Segraves, R. T., Huang, L., & Rosen, R. C. (2012) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2011.569642 · Cited by 39
Mechanism of action of A-85380 in an animal model of depression
Buckley, M. J., Surowy, C. S., Meyer, M., & Curzon, P. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.012 · Cited by 39
Increased Frequency and Range of Sexual Behavior in a Patient with Parkinson’s Disease After Use of Pramipexole: A Case Report
Munhoz, R. P., Fabiani, G., Becker, N., & Teive, H. A. G. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00861.x · Cited by 39
The impact of experiences of ageism on sexual activity and interest in later life
HEYWOOD, W., Minichiello, V., Lyons, A., Fileborn, B., Hussain, R., Hinchliff, S., Malta, S., Barrett, C., & Dow, B. (2017) · Ageing and Society · doi:10.1017/s0144686x17001222 · Cited by 39
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay
Jacobsen, N. W., Hansen, C. H., Nellemann, C., Styrishave, B., & Halling‐Sørensen, B. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.07.005 · Cited by 38
Modest effects of repeated fluoxetine on estrous cyclicity and sexual behavior in Sprague Dawley female rats
Maswood, N., Sarkar, J., & Uphouse, L. L. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.063 · Cited by 37
Drugs that cause sexual dysfunction
Smith, S. M. (2007) · Psychiatry · doi:10.1016/j.mppsy.2006.12.004 · Cited by 38
Links among Paroxetine-Induced Sexual Dysfunctions, Gender, and CYP2D6 Activity
Žourková, A., Češková, E., Hadašová, E., & Ravčuková, B. (2007) · Journal of Sex & Marital Therapy · doi:10.1080/00926230701385589 · Cited by 36
“One problem frequently mentioned and discussed in association with anti-depressant therapy, mainly with anti-depressants from among selective serotonin reuptake inhibitors (SSRIs), is sexual dysfunction disorders (Gregorian et al., 2002; Lane, 1997).”
Background
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans
Break, T. J., Desai, J. V., Natarajan, M., Ferre, E. M. N., Henderson, C., Zelazny, A. M., Siebenlist, U., Hoekstra, W. J., Schotzinger, R. J., Garvey, E. P., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx352 · Cited by 34
Depression and Sexual Functioning in Minority Women: Current Status and Future Directions
Dobkin, R. D., Leiblum, S. R., Rosen, R. C., Menza, M. A., & Marín, H. (2005) · Journal of Sex & Marital Therapy · doi:10.1080/00926230500229251 · Cited by 37
Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia
Roy-Desruisseaux, J., Landry, J., Bocti, C., Tessier, D., Hottin, P., & Trudel, J.-F. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q214 · Cited by 32
Examining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depression
Czéh, B., Pudovkina, O., van der Hart, M. G. C., Simon, M., Heilbronner, U., Michaelis, T., Watanabe, T., Frahm, J., & Fuchs, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2184-8 · Cited by 33
Effects of selective serotonin reuptake inhibitors on endocrine system (Review)
Ruiz‐Santiago, C., Rodríguez‐Pinacho, C., Pérez‐Sánchez, G., & Acosta-Cruz, E. (2024) · Biomedical Reports · doi:10.3892/br.2024.1816 · Cited by 33

Authors: Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M.
Affiliations: Lewin Group (United States) (US)
Icahn School of Medicine at Mount Sinai (US)
GlaxoSmithKline (United States) (US)
GlaxoSmithKline (United Kingdom) (GB)
Corresponding author: Goodman, Clifford
ORCID: Goodman, Clifford
Venue: Annals of Pharmacotherapy
Publisher: SAGE Publications
Published: 2002-10
Volume: 36
Issue: 10
Pages: 1577-1589
ISSN: 0012-6578 (ISSN-L)
1060-0280
1542-6270
DOI: 10.1345/aph.1a195
OpenAlex: W2171466849
Cited by: 320
References: 71
Citations by year: 2026: 3 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 18 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 15 · 2017: 6 · 2016: 12 · 2015: 13 · 2014: 17 · 2013: 22 · 2012: 22
FWCI: 7.68
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Annals of Pharmacotherapy (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: antidepressant-induced sexual dysfunction, selective serotonin reuptake inhibitors, adverse drug reactions, fluoxetine, sertraline, paroxetine, bupropion, nefazodone, mirtazapine, depression treatment, medication adherence
MeSH terms: Antidepressive Agents, Clinical Trials as Topic, Depressive Disorder, Female, Humans, Libido, Male, Selective Serotonin Reuptake Inhibitors, Sexual Dysfunctions, Psychological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antidepressant-Induced Sexual Dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks